Scientists unlock gender key to treating stroke

January 27, 2014
Scientists unlock gender key to treating stroke

(Medical Xpress)—Stroke is Australia's second biggest killer after coronary heart disease and a leading cause of disability, and there is no treatment for the disease which costs the Australian economy more than $49 million every year.

It has long been known that a gender difference exists among - the incidence of stroke is higher in men up to the age of 75, similar in the 75-84 age group, and higher in women in the age group greater than 85. Why this is the case has been largely a mystery, but it has been suspected to at least partly relate to the presence or absence of oestrogen.

Researchers at Monash University's Faculty of Biomedical and Psychological Sciences studied a little known oestrogen receptor that occurs in men and women. They have found that by blocking this receptor in males they can alleviate the symptoms of stroke if given up to four hours after the event. However – they have also shown that – by triggering this receptor in older women, it has the potential to protect females from the harmful effects of stroke.

The results have been published in the prestigious international journal, Stroke. It is the first time that a drug with the potential to reduce and even stop the effect of a stroke in a sex-specific manner has been found and is considered a significant breakthrough in stroke research.

According to Associate Professor Chris Sobey, it has been well known in the past that there are two for oestrogen. However over in the last decade a third was found in heart, blood vessels and brain tissue. Sobey, Dr Brad Broughton and their team discovered that the receptor behaves completely differently in males and females following a stroke.

Using mouse models, the researchers found that the receptor – called GPER – when triggered following a stroke makes the stroke outcome worse in older males but better in older females. Targeting the receptor has no effect in younger females, presumably because of the competing effects of high levels of oestrogen naturally present, "which is fine because we are essentially looking at women who are post-menopausal as the main female patients who suffer strokes," Associate Professor Sobey said.

The researchers have also found the same pattern exists for changes in receptor levels in both mouse and human brain tissue in as well as controls, opening the way for new ways to effectively treat the disease, depending on the gender of the patient.

"It is quite conceivable that a post-menopausal woman presenting at the ER with a stroke would be treated by stimulating this receptor through a targeted drug, whereas a man of similar age would receive a GPER blocker – each respective treatment should similarly halt the symptoms of the ," Associate Professor Sobey said.

Explore further: Stroke risk similar among men and women smokers worldwide

Related Stories

Stroke risk similar among men and women smokers worldwide

August 22, 2013
Smoking cigarettes may cause similar stroke risks for men and women, but women smokers may be at greater risk for a more deadly and uncommon type of stroke, according to new research in the American Heart Association journal ...

Stroke risk in elderly treated with antipsychotics is newly linked to specific drug actions

March 11, 2013
Antipsychotic administration in the elderly is associated with an increased risk for cerebrovascular accident, more commonly known as stroke; a new study published in Biological Psychiatry provides additional insight into ...

Peritoneal dialysis as an intervention for stroke patients

September 3, 2013
Ischemic stroke is characterized by an interruption of the blood supply to the brain, which can lead to brain damage and even death. Excess amounts of the excitatory neurotransmitter glutamate are released during stroke events ...

New global stroke repository offers regional comparative statistics

January 7, 2014
In many countries strokes are seen as a lower priority when compared to other diseases despite their public health impact. This is partly due to a lack of readily accessible data to make the case for the development of national ...

Anxiety linked to higher long-term risk of stroke

December 19, 2013
The greater your anxiety level, the higher your risk of having a stroke, according to new research published in the American Heart Association journal Stroke.

Delay in seeking stroke care costs women best treatment

July 25, 2013
Women with clot-caused strokes are less likely than men to arrive at the hospital in time to receive the best treatment, according to a European study reported in the American Heart Association journal Stroke.

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.